Life-long Tele-monitoring of Patients With Type 2 Diabetes Mellitus in Central Greece
NCT ID: NCT01498367
Last Updated: 2015-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
154 participants
INTERVENTIONAL
2011-03-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Managing Diabetes During Pregnancy in the Wireless Age
NCT01474525
Effects of Telemonitoring and Telemedicine Service for Type 2 Diabetes Care
NCT01345435
Study of the Effect of Telemedicine on Glycemic Control for Patients With Diabetes and Treated With Insulin
NCT04883372
Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin
NCT01175408
Telemedicine Continuous Remote Monitoring of Adults With Uncontrolled Diabetes Mellitus
NCT05161793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Measurements of HbA1c will be taken to assess glycaemic control while the dietary and the exercise habits will be assessed by the use of questionnaires. In addition the patients' satisfaction from the use of the telemedicine service will be studied. A Cost-Effective Analysis and Cost Utility Analysis will be applied to evaluate the tele-health service compared with the usual care from the health and social perspective. The effect of the tele-health service in the organization structure of the outpatient hospital department will be evaluated with a qualitative study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
Participants in the control group receive usual care. Usual care consists of regular visits to the specialist when required. In the occasion of the visit, HbA1c and glucose measurements are performed and the current oral or insulin therapy is modified if necessary. Patients also receive basic education in the management of diabetes.
No interventions assigned to this group
Telemonitoring of diabetes 2 patients
Patients will have one educational visit to set up the system and explain how it works. Patients will download their measurements from their tele-glucose meter to their mobile phone and the data will be transferred to the regional database. The care team (a nurse specially trained and the allocated physician) will regularly access the patient's home diary, and will provide the appropriate counselling and medication changes as frequently as necessary. In addition to blood glucose measurements, routine questions about symptoms and eventual difficulties related to diabetes as well as diabetic management will be routinely captured and reported.
Telemonitoring of patients with diabetes type 2
Telemonitoring of the patients's blood glucose level measurements using a the tele-glucose meter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemonitoring of patients with diabetes type 2
Telemonitoring of the patients's blood glucose level measurements using a the tele-glucose meter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HbA1c \> 53 mmol/mol (7.0 % according to NGSP)
* Capability to use the devices provided
* Being cognitively able to participate
* Capability of filling in questionnaires in german or greek language
* Absence of severe comorbidity prevalent on diabetes with life expectancy \< 12 months
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry for Health and Social Solidarity, Greece
OTHER
Municipality of Trikala, Greece
OTHER
e-Trikala S.A.
INDUSTRY
Cities Net SA
INDUSTRY
Institute of Biomedical Research & Technology, Larissa, Greece
OTHER
Institute of Communications and Computer Systems, Athens, Greece
OTHER
Alexander Technological Educational Institute, Thessaloniki, Greece
OTHER
University of Macedonia, Thessaloniki, Greece
OTHER
University of Thessaly
OTHER
Regional Health Authority of Sterea & Thessaly
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Georgios Koukoulis
Associate Proffesor, Director of the Endocrinology and Metabolic Diseases Department, University Hospital of Larissa
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georgios Koukoulis, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Endocrinology and Metabolic Diseases Department - Regional University Hospital of Larisa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Endocrinology and Metabolic Diseases Department - Regional University Hospital of Larisa
Larissa, Thessaly, Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab. 2009 Oct;11(10):913-30. doi: 10.1111/j.1463-1326.2009.01057.x. Epub 2009 Jun 16.
Klonoff DC. Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical? Diabetes Care. 2003 May;26(5):1626-8. doi: 10.2337/diacare.26.5.1626. No abstract available.
Jaana M, Pare G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract. 2007 Apr;13(2):242-53. doi: 10.1111/j.1365-2753.2006.00686.x.
Related Links
Access external resources that provide additional context or updates about the study.
"The Renewing Health project is partially funded under the ICT Policy Support Programme (ICT PSP) as part of the Competitiveness and Innovation Framework Programme by the European Community"
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC Grant Agreement 250487
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
FR2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.